Virginia (202) 466-6937 | Arizona (602) 388-8899

Jonathan Emord appears on Coast to Coast AM with George Noory

Jonathan Emord appeared for two hours on the nationally syndicated radio program “Coast to Coast” with George Noory on September 9, 2019 from 9PM to Midnight Pacific.  Jonathan discussed the opioid crisis, FDA complicity in the acts of major pharmaceutical companies in promotions that caused it, Trump’s efforts to stem the crisis, the Oklahoma public […]

PRESS RELEASE: Jonathan Emord Goes Round Two with the FDA on Electroshock Devices

For Immediate Release:  23 August 2017 Contact:  Dr. Linda Lagemann, Liaison to the Petitioners (415-640-7343)   Attorney Jonathan Emord and his co-counsel Kendrick Moxon have filed a Supplement to their Citizen Petition of August 2016, protesting the FDA’s Proposed Order to reclassify and make more readily available the Electroconvulsive Therapy (ECT) Device used to give […]

Jonathan Emord, “The FDA’s bow to barbarism” (Washington Times, Oct. 12, 2016)

Read Jonathan Emord’s October 12, 2016 article in the Washington Times concerning the FDA’s untenable decision to downgrade Electroconvulsive Therapy (ECT) medical devices from Class III to Class II: The FDA’s bow to barbarism:  Downgrading the brain injury risks from shock therapy is unjustified (Oct. 12, 2016) (opens in new window)

D.C. Circuit: FTC’s Two RCT Requirement Violates the First Amendment

On January 30, 2015, the Circuit Court of Appeals for the District of Columbia entered its decision in the case of POM Wonderful, LLC (“POM”) v. Federal Trade Commission (“FTC”), No. 13-1060.  In that decision, the D.C. Circuit upheld the FTC’s findings that POM violated the Federal Trade Commission Act (“FTCA”) by misleading consumers through […]

Proposed Federal Bill Would Prevent States, FDA, And Anyone Else From Informing Consumers Whether Food Is Bioengineered

  By Eric Awerbuch In April, 2014, five members of Congress introduced a bill, H.R. 4432 (hereinafter “the Bill”) seeking to regulate, among other things, the labeling of bio-engineered food products.[i]  The Bill, also known as the “Safe and Accurate Food Labeling Act of 2014,” is remarkable in that it:  1) prohibits the States from […]

New regulations on laundry detergent pods would be cumulative, inefficient, and an example of why our federal regulations cost as much as Canada’s entire GDP

By Eric Awerbuch The federal government is once again using tragedy to procure more regulatory power over private business.  Beginning in 2012, laundry detergent businesses began selling detergent pods—small, single-use packets of concentrated detergent encased in a water soluble membrane.[1]  Instead of having to pour and measure (an occasionally messy endeavor), Americans can insert one […]

Emord Interview in Freedom From Choice to Appear on the Stossel Show

Tim Delmastro, the director and co-producer of Freedom From Choice, winner of the Best International Documentary award, will be interviewed tomorrow night on the Stossel Show about his feature-length film. Freedom From Choice investigates the loss of our liberties.  It asks whether our daily choices, from what we eat to what we read, are in […]

FDA Requests Nominations for Drug Compounding List

President Obama signed the Drug Quality and Security Act (“DQSA”) into law on November 27, 2013.  The DQSA contained provisions concerning the oversight of human drug compounding.   For instance, it removed provisions of section 503A of the federal Food, Drug, and Cosmetic Act (“FDCA”) that the U.S. Supreme Court previously held were unconstitutional, thereby ensuring […]

CMS Final Rule Benefits Qualified Nutritionists

On behalf of the Certification Board for Nutrition Specialists (“CBNS”), Emord & Associates, P.C. submitted comments on proposed revisions to 42 C.F.R. § 482.28, which concerns food and dietetic services.  The Centers for Medicare & Medicaid Services (“CMS”) agreed with CBNS’ comments and incorporated its suggestions into the final rule, 79 Fed. Reg. 27105 (May […]

Whether evaluating a concept, performing regulatory due diligence, maintaining or prosecuting regulatory filings, or contesting adverse litigation, Emord & Associates provides exceptional counsel for all your litigation and regulatory needs.

Virginia (Firm HQ)

11808 Wolf Run Lane
Clifton, VA 20124
Telephone: (202) 466-6937
Telecopier: (202) 466-6938


2730 S. Val. Vista Dr.
Bldg. 6, Ste 133
Gilbert, AZ 85295
Telephone: (602) 388-8899
Telecopier: (602) 393-4361